ERAS · NASDAQ · STOCK
Erasca, Inc.
$17.67
52W $1.33 – $24.28
62/100
$6.36B
-19.3
0.67
Is ERAS Bullish or Bearish?
Bullish.
Innellis AI committee rates Erasca, Inc. (ERAS) Buy with a composite score of 62/100
, based on 5 analysts with 60% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.42 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.58 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- ROE of only -77.0% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 16.7% signals elevated volatility — Risk
- No news coverage in the last 14 days -- limited independent confirmation either way — News
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
62/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 35%
of 192 Healthcare peers
Value Analyst
neutral
52
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -77.0% -- cheap may mean cheap for a reason
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 16.7% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
60
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
− No news coverage in the last 14 days -- limited independent confirmation either way
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
48.1
Neutral
MACD Histogram
-0.204
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$8.71
Resistance
$24.28
Bollinger %B
0.35
Inside Bands
Price vs Moving Averages
EMA 9
$18.33
Below
EMA 21
$18.27
Below
EMA 50
$17.16
Above
EMA 200
$12.33
Above
Fundamental Analysis
Valuation
67
Profitability
0
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio
-19.3×
P/B Ratio
15.75×
PEG Ratio
0.17
Dividend Yield
0.00%
52W High
$24.28
52W Low
$1.33
Quality & Growth
ROE
-3830.2%
ROA
-3143.9%
Gross Margin
0.0%
Operating Margin
0.0%
Revenue Growth YoY
—
Debt / Equity
0.12
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -19.3 (inexpensive relative to a 15-40x range); Price-to-book of 15.8x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -38.3%; Return on assets of -31.4%; Net margin of 0.0%; Gross margin of 0.0%; Current ratio of 8.29 (healthy short-term liquidity); Debt-to-equity of 0.12; Free cash flow per share is negative (-0.32); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full ERAS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →